As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.
12 Analysts have issued a Achieve Life Sciences, Inc. forecast:
12 Analysts have issued a Achieve Life Sciences, Inc. forecast:
Jun '25 |
+/-
%
|
||
Revenue | - - |
-
|
|
Gross Profit | - - |
-
|
|
EBITDA | -50 -50 |
100%
100%
|
EBIT (Operating Income) EBIT | -50 -50 |
99%
99%
|
Net Profit | -50 -50 |
83%
83%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
Head office | United States |
CEO | Richard Stewart |
Employees | 25 |
Founded | 1991 |
Website | achievelifesciences.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.